The global neuroendoscopy devices market is currently being driven by the growing number of patients suffering from cancer. It is one of the most widely used procedures for the removal of acoustic neuromas, metastatic brain tumors, pituitary tumors, and skull base tumors. Transparency Market Research carefully examines the scope and dynamics of the global neuroendoscopy devices market in a report titled “Neuroendoscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023.”
Get Free Sample Research Report:
Endoscopy devices are commonly used in tumor removal procedures as they offer several advantages over other methods. In the case of neuroendoscopy, the removal of the tumor is done through the nasal cavity or through a small hole made in the skull. A neuroendoscopy is the least invasive procedure and allows medical professionals to remove the tumor without hurting any adjacent healthy tissues. This procedure also allows them greater access to the cranial cavity than other conventional procedures. Therefore, this method is less painful, more accurate, and the wounds are quicker to heal than conventional tumor removal surgeries.
Based on the type of surgery, the global neuroendoscopy devices market is segmented into the transnasal neuroendoscopy, transcranial neuroendoscopy, and intra ventricular neuroendoscopy. Among these, the global neuroendoscopy devices market is currently led by intra ventricular neuroendoscopy devices. This segment is also expanding at the fastest CAGR among all surgery types owing to the larger number of medical professionals that prefer the intra ventricular method.
Several advancements in endoscopy technologies are being applied to propel the growth rate of the global neuroendoscopy devices market. For instance, there is an increase in the use of HD cameras in this market as they allow medical practitioners to gain a much more accurate handle over the procedure. On the other hand, the high cost of neuroendoscopy surgeries is still restricting the overall market growth.
Geographically speaking, the global neuroendoscopy devices market is dominated by North America and Europe, collectively holding the largest share in the market owing to a high demand for diagnostic tests and the advanced nature of neuroendoscopy devices. The markets in these regions further benefit from the increasing number of government initiatives.
The Asia Pacific and RoW neuroendoscopy devices markets are largely untapped as the lack of optimum infrastructure is preventing the practice of neuroendoscopy in these regions. Asia Pacific is, however, showing rapid progress owing to developing healthcare infrastructure and rising medical expenditures.
The key players in the global neuroendoscopy devices market are Conmed Corporation, Accellent Inc., C.R. Bard Inc., Aesculap Inc., Arthrex Inc., Cook Medical Incorporated, Given Imaging Inc., Johnson & Johnson, Fujifilm Holding Corporation, Karl Storz GMBH & CO. KG, Boston Scientific Corporation, Hoya Corporation, Olympus Corporation, and Boston Scientific Corporation.
Full Research Report on Global Neuroendoscopy Devices Market: